These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 10912622)

  • 21. Delivery of protein antigens and DNA by attenuated intracellular bacteria.
    Gentschev I; Dietrich G; Spreng S; Pilgrim S; Stritzker J; Kolb-Mäurer A; Goebel W
    Int J Med Microbiol; 2002 Feb; 291(6-7):577-82. PubMed ID: 11890559
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of plasmid DNA encoding the porcine granulocyte-macrophage colony-stimulating factor on antigen-presenting cells in pigs.
    Melkebeek V; Van den Broeck W; Verdonck F; Goddeeris BM; Cox E
    Vet Immunol Immunopathol; 2008 Oct; 125(3-4):354-60. PubMed ID: 18762341
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mucosal delivery of a transmission-blocking DNA vaccine encoding Giardia lamblia CWP2 by Salmonella typhimurium bactofection vehicle.
    Abdul-Wahid A; Faubert G
    Vaccine; 2007 Dec; 25(50):8372-83. PubMed ID: 17996337
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiple effector mechanisms induced by recombinant Listeria monocytogenes anticancer immunotherapeutics.
    Wallecha A; Carroll KD; Maciag PC; Rivera S; Shahabi V; Paterson Y
    Adv Appl Microbiol; 2009; 66():1-27. PubMed ID: 19203646
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Listeria monocytogenes as novel carrier system for the development of live vaccines.
    Schoen C; Loeffler DI; Frentzen A; Pilgrim S; Goebel W; Stritzker J
    Int J Med Microbiol; 2008 Jan; 298(1-2):45-58. PubMed ID: 17936682
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting the mucosa: genetically engineered vaccines and mucosal immune responses.
    Stevceva L; Abimiku AG; Franchini G
    Genes Immun; 2000 Jun; 1(5):308-15. PubMed ID: 11196691
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel bacterial systems for the delivery of recombinant protein or DNA.
    Spreng S; Dietrich G; Niewiesk S; ter Meulen V; Gentschev I; Goebel W
    FEMS Immunol Med Microbiol; 2000 Apr; 27(4):299-304. PubMed ID: 10727885
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improving live attenuated bacterial carriers for vaccination and therapy.
    Loessner H; Endmann A; Leschner S; Bauer H; Zelmer A; zur Lage S; Westphal K; Weiss S
    Int J Med Microbiol; 2008 Jan; 298(1-2):21-6. PubMed ID: 17702649
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recruitment of different subsets of antigen-presenting cells selectively modulates DNA vaccine-elicited CD4+ and CD8+ T lymphocyte responses.
    McKay PF; Barouch DH; Santra S; Sumida SM; Jackson SS; Gorgone DA; Lifton MA; Letvin NL
    Eur J Immunol; 2004 Apr; 34(4):1011-20. PubMed ID: 15048711
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of a DNA vaccine delivered in attenuated Salmonella typhimurium against Eimeria tenella infection in chickens.
    Du A; Wang S
    Int J Parasitol; 2005 Jun; 35(7):777-85. PubMed ID: 15890351
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bacterial ghosts as adjuvant particles.
    Riedmann EM; Kyd JM; Cripps AW; Lubitz W
    Expert Rev Vaccines; 2007 Apr; 6(2):241-53. PubMed ID: 17408373
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SopB of Salmonella enterica serovar Typhimurium is a potential DNA vaccine candidate in conjugation with live attenuated bacteria.
    Nagarajan AG; Balasundaram SV; Janice J; Karnam G; Eswarappa SM; Chakravortty D
    Vaccine; 2009 May; 27(21):2804-11. PubMed ID: 19428891
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protective effect of a DNA vaccine delivered in attenuated Salmonella typhimurium against Toxoplasma gondii infection in mice.
    Qu D; Wang S; Cai W; Du A
    Vaccine; 2008 Aug; 26(35):4541-8. PubMed ID: 18590785
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improving DNA vaccine potency via modification of professional antigen presenting cells.
    Hung CF; Wu TC
    Curr Opin Mol Ther; 2003 Feb; 5(1):20-4. PubMed ID: 12669466
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non-viral vector as vaccine carrier.
    Chen WC; Huang L
    Adv Genet; 2005; 54():315-37. PubMed ID: 16096017
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DNA vaccines--challenges in delivery.
    Pachuk CJ; McCallus DE; Weiner DB; Satishchandran C
    Curr Opin Mol Ther; 2000 Apr; 2(2):188-98. PubMed ID: 11249641
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Delivery of antigen-encoding plasmid DNA into the cytosol of macrophages by attenuated suicide Listeria monocytogenes.
    Dietrich G; Bubert A; Gentschev I; Sokolovic Z; Simm A; Catic A; Kaufmann SH; Hess J; Szalay AA; Goebel W
    Nat Biotechnol; 1998 Feb; 16(2):181-5. PubMed ID: 9487527
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DNA vaccines increase immunogenicity of idiotypic tumor antigen by targeting novel fusion proteins to antigen-presenting cells.
    Fredriksen AB; Sandlie I; Bogen B
    Mol Ther; 2006 Apr; 13(4):776-85. PubMed ID: 16414309
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An attenuated Salmonella oral DNA vaccine prevents the growth of hepatocellular carcinoma and colon cancer that express alpha-fetoprotein.
    Chou CK; Hung JY; Liu JC; Chen CT; Hung MC
    Cancer Gene Ther; 2006 Aug; 13(8):746-52. PubMed ID: 16410824
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A single dose of oral DNA immunization delivered by attenuated Salmonella typhimurium down-regulates transgene expression in HBsAg transgenic mice.
    Zheng BJ; Ng MH; Chan KW; Tam S; Woo PC; Ng SP; Yuen KY
    Eur J Immunol; 2002 Nov; 32(11):3294-304. PubMed ID: 12555675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.